Stephen J. LeGrue
About
In The Last Decade
Stephen J. LeGrue
32 papers receiving 603 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 313
- Immunology 201
- Pediatrics, Perinatology and Child Health 117
- Oncology 115
- Transplantation 93
Countries citing papers authored by Stephen J. LeGrue
This map shows the geographic impact of Stephen J. LeGrue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. LeGrue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. LeGrue more than expected).
Fields of papers citing papers by Stephen J. LeGrue
This network shows the impact of papers produced by Stephen J. LeGrue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. LeGrue. The network helps show where Stephen J. LeGrue may publish in the future.
Co-authorship network of co-authors of Stephen J. LeGrue
This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. LeGrue. A scholar is included among the top collaborators of Stephen J. LeGrue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. LeGrue. Stephen J. LeGrue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 49 | |
| 3 | Inhibition of experimental metastasis and extracellular matrix degradation by butanol extracts from B16-F1 murine melanoma. | 19 |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 11 | |
| 7 | Immunological characteristics of immunogenic variants induced in the MCA-F murine fibrosarcoma using 1-methyl-3-nitro-1-nitrosoguanidine, 5-aza-2'-deoxycytidine, or ultraviolet radiation. | 4 |
| 8 | Differential extraction of tumor-specific antigens from two ultraviolet light-induced murine fibrosarcomas with the use of 1-butanol. | 4 |
| 9 | Inhibition of T-lymphocyte proliferation by the cyclic polypeptide didemnin B: no inhibition of lymphokine stimulation. | 20 |
| 10 | Identification of cell surface cathepsin B-like activity on murine melanomas and fibrosarcomas: modulation by butanol extraction. | 21 |
| 11 | Systemic macrophage activation by liposomes containing MTP-PE in mice immunosuppressed with cyclosporine. | 2 |
| 12 | 61 | |
| 13 | 19 | |
| 14 | 17 | |
| 15 | Identification of virus epitopes copurifying with tumor specific transplantation antigens. Abstr. | 1 |
| 16 | Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials. | 9 |
| 17 | 89 | |
| 18 | 14 | |
| 19 | Immunobiological properties of 1-butanol-extracted cell surface antigens. | 28 |
| 20 | Cell surface alterations on colon adenocarcinoma cells. | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.